Contact:
Astrid Nolte
Phone: + 43 - 1 - 811 40 - 319
E-Mail: editor@newsfox.com
| Pressbox | 
|
Munich (pte036/05.02.2003/12:37) - Leading European biotech growth companies, corporate experts and investors are coming to Munich to exchange insights on the biotech industry during the 5th Biotech & Finance Forum http://www.e-unlimited.com/ on 11 and 12 February 2003.
Up to 60 presenting companies, as well as representatives from the European Investment Fund (EIF) and European Investment Bank (EIB), will exchange information on the latest developments in the biotech sector.
The forum is conceived as an ideal setting for new business development, meeting potential investors and high-end networking. It is the fifth in a series of exclusive forums designed to assemble a select group of business visionaries and entrepreneurs who will join with top venture capitalists, investment professionals and financial institutions in the biotechnology sectors.
The forum's programme includes two technology summit sessions on drugs discovery, toolkits & hybrids, and therapeutics, and focuses on such topics as "Corporate Outlook", "Capital Outlook" and "Corporate Insight". Keynote speakers are Medigene CEO Dr Peter Heinrich, Bio-M CEO Professor Horst Domdey, and DG Research Director and European Commission member Dr Bruno Hansen.
Confirmed sponsors include Sofinnova Partners, Ventech, 3i, Atlas Venture, Bio Fund, Global Life Sciences, TVM, Medigene, Biogen, Roche, Innogenetics, Transgene, Dresdner Kleinwort Wassertein, GPC Biotech, Genzyme, Novartis, and Procter & Gamble.
To register go to http://www.e-unlimited.com/
For more information please contact:
Europe Unlimited SA
Place E. Flagey 7
B-1050 Brussels
Tel: +32 (0)2 644 65 80
Fax: +32 (0)2 644 65 81
General information: biotechforum@e-unlimited.com
Presenting companies: nominations@e-unlimited.com
Sponsorship opportunities: sponsorship@e-unlimited.com
Partnership opportunities: partnership@e-unlimited.com
|
|
